Summary
The serum levels of total immunoreactive insulin (IRI) and proinsulin-like component (PLC) in the fasting state and following the administration of insulin secretagogues in 5 patients with organic hyperinsulinism and age and sex matched normal subjects are reported. Diagnosis of organic hyperinsulinism could be established in all instances on the basis of the inappropriately high total serum IRI levels for the corresponding blood glucose values; such an abnormal relationship was not seen in normal subjects, and was further enhanced by insulin secretagogues. Unrestrained insulin secretion in organic hyperinsulinism was enhanced following the administration of glucose, tolbutamide, glucagon or amino acids; the last 2 stimuli are known to be ineffective in causing insulin secretion in the presence of hypoglycemia in normal subjects. Four patients had insulinomas and one probably had islet cell hyperplasia or abnormal function of islet cells. Chromatography of serum IRI to quantitate PLC is a useful adjunct to the diagnosis of organic hyperinsulinism as in the fasting state the proportion of PLC is always elevated, above the normal range of 5–22%. Following the administration of insulin secretagogues there was pronounced increase in total serum IRI in organic hyperinsulinism but the proportion of PLC generally decreased, suggesting thereby that major increase in IRI was due to release of stored granular IRI which is known to have a low proportion of PLC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Creutzfeldt W., Arnold R., Creutzfeldt C., Deuticke U., Frerichs H., Track N. S.: Biochemical and Morphological Investigations of 30 Human Insulinomas. Correlation between the Tumour Content of Insulin and Proinsulin-Like Components and the Histological and Ultrastructural Appearance — Diabetologia9, 217, 1973.
Floyd J. C. Jr., Fajans S. S., Knoff R. F., Conn J. W.: Plasma Insulin in Organic Hyperinsulinism: Comparative Effects of Tolbutamide, Leucine and Glucose — J. clin. Endocr.24, 747, 1964.
Goldsmith S. J., Yalow R. S., Berson S. A.: Significance of Human Plasma Insulin Sephadex Fractions — Diabetes18, 834, 1969.
Gutman R. A., Lazarus N. R., Penhos J. C., Fajans S. S., Recant L.: Circulating Proinsulin-Like Material in Patients with Functioning Insulinomas — New Engl. J. Med.284, 1003, 1971.
Horwitz D. L., Starr J. I., Mako M. E., Blackard W. G., Rubenstein A. H.: Proinsulin, Insulin, and C-Peptide Concentrations in Human Portal and Peripheral Blood — J. clin. Invest.55, 1278, 1975.
Khurana R. C., Klayton R., Jung Y., Gonzalez A. R., Dhawer V. P., Corredor D. G., Sieracki J. C., Danowski T. S.: Insulin and Glucose Patterns in Control Subjects and in Proved Insulinoma — Amer. J. med. Sci.262, 115, 1971.
Kumar D., Mehtalia S. D.: Glucagon-Induced Proinsulin and Insulin Response in Patients with Insulinoma — In:Rastogi G. K. (Ed.): Abstracts of Fifth Asia & Oceania Congr. Endocr., Chandigarh 1974. Endocr. Soc. India Publ., Chandigarh, 1974; p. 95.
Kumar D., Mehtalia S. D., Miller L. V.: Diagnostic Use of Glucagon-Induced Insulin Response. Studies in Patients with Insulinoma or Other Hypoglycemic States — Ann. intern. Med.80, 697, 1974.
Lindall A. W., Wong E. T., Sorenson R. I., Steffes M. W.: Proinsulin and Insulin Content of Subcellular Fractions from an Islet Adenoma — J. clin. Endocr.34, 718, 1972.
Marks V.: Progress Report. Diagnosis of Insulinoma — Gut12, 835, 1971.
Marks V., Rose F. C.: Hypoglycaemia — Blackwell Sci. Publ., Oxford, 1965; pp. 109 and 115.
Melani F., Rubenstein A. H., Steiner D. F.: Human Serum Proinsulin — J. clin. Invest.49, 497, 1970.
Melani F., Ryan W. G., Rubenstein A. H., Steiner D. F.: Proinsulin Secretion by a Pancreatic Beta-Cell Adenoma. Proinsulin and C-Peptide Secretion — New Engl. J. Med.283, 713, 1970.
Nelson N.: A Photometric Adaptation of Somogyi Method for Determination of Glucose — J. biol. Chem.153, 375, 1944.
Rastogi G. K., Letarte J., Fraser T. R.: Immunoreactive Insulin Content of 203 Pancreases from Foetuses of Healthy Mothers — Diabetologia6, 445, 1970.
Rastogi G. K., Letarte J., Fraser T. R.: Proinsulin Content of Pancreas in Human Fœtuses of Healthy Mothers — Lancet1, 7, 1970.
Rastogi G. K., Sinha M. K., Dash R. J.: Insulin and Proinsulin Content of Pancreases from Diabetic and Non-Diabetic Subjects — Diabetes22, 804, 1973.
Sawhney B. B., Chopra J. S., Rastogi G. K., Kataria R. N.: Hyperinsulinism and Neuroglycopenic Syndromes — Neurology (Bombay)23, 121, 1975.
Sherman B. M., Pek S., Fajans S. S., Floyd J. C., Jr., Conn J. W.: Plasma Proinsulin in Patients with Functioning Pancreatic Islet Cell Tumors — J. clin. Endocr.35, 271, 1972.
Unger R. H.: Alpha- and Beta-Cell Interrelationships in Health and Disease — Metabolism23, 581, 1974.
Welborn T. A., Fraser T. R.: The Double Antibody Immunoassay of Insulin. A Standardized Second Antibody Reaction that Eliminates Spurious Results with Human Serum — Diabetologia1, 211, 1965.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rastogi, G.K., Sialy, R., Sinha, M.K. et al. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism. Acta diabet. lat 12, 309–323 (1975). https://doi.org/10.1007/BF02581104
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581104